Clinica Chimica Acta · 2021 · 36 citations · 13 references
MedicineMaternal HealthObstetricsHigh-risk PregnancyMaternal-fetal MedicinePrenatal DiagnosisAntenatal AssessmentAntenatal Risk AssessmentFetal Anomaly DetectionPregnancyPrenatal CarePrenatal Risk AssessmentAntenatal Screening AlgorithmsBiochemical Screening MarkersChromosomal Abnormality DetectionChromosomal Abnormality ScreeningPredictive Modeling In PregnancyPrenatal Diagnosis Of Down SyndromePrenatal Screening ModelsSecond-trimester Prediction
BACKGROUND: Down syndrome (DS) is the most common human chromosomal abnormality. About 1200 laboratories carry out antenatal screening for DS in second trimester pregnancies in China. Their prenatal assessment of DS pregnancy risk is based on biometric calculations conducted on maternal serum biochemical markers and ultrasonic markers of fetal growth. However, the performance of this triple test for DS in second trimester pregnancies has a false positive rate of 5%, and a detection rate of about 60%∼65%. METHOD: A total of 58,972 pregnant women, including 49 DS cases, who had undergone DS screening in the second trimester were retrospectively included and a machine learning (ML) model based on random forest was built to predict DS. In addition, the model was applied to another hospital data set of 27,170 pregnant women, including 27 DS cases, to verify the predictive efficiency of the model. RESULTS: The ML model gave a DS detection rate of 66.7%, with a 5% false positive rate in the model data set. In the external verification data set, the ML model achieved a DS detection rate of 85.2%, with a 5% false positive rate . In comparison with the current laboratory risk model, the ML model improves the DS detection rate with the same false positive rate, while the difference has no significance. CONCLUSIONS: The ML model for DS detection described here has a comparable detection rate with the same false positive rate as the DS risk screening software currently used in China. Our ML model exhibited robust performance and good extrapolation, and could function as an alternative tool for DS risk assessment in second trimester maternal serum.
13
Scikit-learn: Machine Learning in Python
Fabián Pedregosa, Gaël Varoquaux, Alexandre Gramfort et al. · arXiv (Cornell University) · 2012 · 63.7K citations · Full text
Maternal serum screening for Down's syndrome in early pregnancy.
N J Wald, Howard Cuckle, J. W. Densem et al. · BMJ · 1988 · 974 citations · Full text
Nicholas Wald, Charles H. Rodeck, Allan Hackshaw et al. · Health Technology Assessment · 2003 · 585 citations · Full text